Reveals the role of kinetic features in regulating cellular outcomes in GPCR signaling, suggesting new avenues for drug design.
Titrating G protein-coupled receptor (GPCR) signaling to achieve desired physiological outcomes without overdose can be accomplished through partial agonism rather than drug dosage.In this study, we use FRET-based biosensors in combination with ordinary differential equation modelling to identify two key kinetic features that determine agonist efficacy: the concentration-dependent association rate of the G protein to the agonist-bound receptor, and the catalytic rate of G protein activation by the receptor.While both rate constants scale proportionally with reported molecular efficacy metrics, we find the concentrationdependent association rate to be the governing parameter across multiple distinct GPCR-ligand pairings.Our model explains discrepancies in signaling outcomes observed between physiological observations and cellular model systems that rely on receptor overexpression.
No takes yet. Share an insight, caveat, or question.
Ritt et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: